Unusual Uptake of [ 131 I] in a Tenosynovial Giant Cell Tumour Relapse in a Patient with Differentiated Thyroid Cancer.
Autor: | Cañete Sánchez FM; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain., Romero Robles LG; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain., Boulvard Chollet XL; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain., Mangas Losada M; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain., Garrastachu P; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain., Cabrera Villegas A; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain., Ramírez Lasanta R; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain., Delgado Bolton R; University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Nuclear Medicine, Logroño, Spain. |
---|---|
Jazyk: | angličtina |
Zdroj: | Molecular imaging and radionuclide therapy [Mol Imaging Radionucl Ther] 2022 Jun 27; Vol. 31 (2), pp. 145-147. |
DOI: | 10.4274/mirt.galenos.2021.40326 |
Abstrakt: | A 77-year-old woman with follicular thyroid cancer underwent total thyroidectomy and subsequent Iodine-131 remnant ablation. She had a history of a wide tenosynovial giant cell tumor (TGCT) of the right wrist and hand that had been resected thirteen years ago. Post-therapeutic scintigraphy and single photon emission computed tomography showed mild uptake on the distal right forearm, wrist and hand. Magnetic resonance imaging and posterior histopathology confirmed a relapse of TGCT. No radioiodine adverse effects were reported after a one-year follow-up. As far as we know, this report is the first in the literature to a TGCT visualized on post-therapy radioiodine scan. Competing Interests: Conflict of Interest: No conflict of interest was declared by the authors. (©Copyright 2022 by Turkish Society of Nuclear Medicine, Molecular Imaging and Radionuclide Therapy published by Galenos Yayınevi.) |
Databáze: | MEDLINE |
Externí odkaz: |